RESUMEN
Methamphetamine (METH) is a powerful psychostimulant that increases glutamate (Glu) levels in the mammalian brain and it is currently known that hippocampi are particularly susceptible to METH. Moreover, it is well established that the overactivation of N-methyl-d-aspartate (NMDA) and AMPA ionotropic Glu receptors causes excitotoxicity. In the present study, we investigated the effect of acute (30 mg/kg) versus escalating dose (ED) administration of METH on NMDA receptor 1, NMDA receptor 2 and glutamate receptor 2 (GluR2) subunit expression in the hippocampus and on memory. Adult Sprague-Dawley rats were injected s.c. during six consecutive days with saline (control and acute groups) or with a growing dose of METH (10, 15, 15, 20, 20, 25 mg/kg/day; ED group). On the 7th day, both METH groups were injected with a 'bolus' of 30 mg/kg METH whereas controls received saline. Western blot analysis showed an increase of GluR2 and NR2A expression levels and no alterations on NR1 subunit in the acute group. On the other hand, in the ED group, GluR2 and NR2A expression levels were unaltered and there was a decrease on NR1 levels. Moreover, we did not observe neurodegeneration with both administration paradigms, as assessed by Fluoro-Jade C staining, but we did observe a strong astrogliosis in the acute administration group by using both immunohistochemistry and Western blot analysis. The impact of METH on working memory was evaluated using the Y maze test and revealed significant mnemonic deficit in the rats acutely treated with the drug. Overall, our results suggest a protection mechanism under conditions of METH administration by decreasing permeability and/or functionality of NMDA and AMPA receptors, which has implications on memory. So, the participation of the glutamatergic system should be considered as an important pharmacological target to design new strategies to prevent or diminish the harmful effect of drug consumption.
Asunto(s)
Hipocampo/efectos de los fármacos , Trastornos de la Memoria/inducido químicamente , Memoria a Corto Plazo/efectos de los fármacos , Metanfetamina/farmacología , Receptores AMPA/efectos de los fármacos , Receptores de N-Metil-D-Aspartato/efectos de los fármacos , Animales , Estimulantes del Sistema Nervioso Central/farmacología , Fluoresceínas , Gliosis/inducido químicamente , Gliosis/metabolismo , Gliosis/fisiopatología , Ácido Glutámico/metabolismo , Hipocampo/metabolismo , Hipocampo/fisiopatología , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Aprendizaje por Laberinto/fisiología , Trastornos de la Memoria/metabolismo , Trastornos de la Memoria/fisiopatología , Memoria a Corto Plazo/fisiología , Degeneración Nerviosa/inducido químicamente , Degeneración Nerviosa/metabolismo , Degeneración Nerviosa/fisiopatología , Compuestos Orgánicos , Subunidades de Proteína/efectos de los fármacos , Subunidades de Proteína/metabolismo , Ratas , Ratas Sprague-Dawley , Receptores AMPA/metabolismo , Receptores de N-Metil-D-Aspartato/metabolismo , Transmisión Sináptica/efectos de los fármacos , Transmisión Sináptica/fisiología , Regulación hacia Arriba/efectos de los fármacos , Regulación hacia Arriba/fisiologíaRESUMEN
Drugs of abuse interfere with the adrenergic activity at the periphery and the study of their effects in vivo at this level may contribute to understand the central mechanisms of action. Free and sulfoconjugated catecholamines and serotonin (5-hydroxytryptamine, 5-HT) were measured by high-performance liquid chromatography with electrochemical detection (HPLC-ECD); plasma dopamine (DA)-beta-hydroxylase (DBH) activity was determined by a HPLC technique. When compared with healthy subjects (n = 49), the results in drug addicts (n = 48) revealed: a) Significant increases in plasma DA (free and sulfoconjugated), epinephrine (Epi)- and norepinephrine (NE)-sulfate levels; b) no significant differences in the levels of plasma free NE or Epi, serum and platelet 5-HT. Concerning DBH activity, there was a tendency for an increase. In conclusion, since catecholamines are rapidly inactivated during blood circulation, the measurement of their sulfates may better reflect catecholamine turnover. The differences found may be interpreted as a reflection of the activation of adrenergic neurotransmission, principally as a consequence of catecholamine uptake blockade by cocaine. Finally, in our conditions the abuse of cocaine plus heroin does not significantly interfere with 5-HT uptake by platelets.
Asunto(s)
Trastornos Relacionados con Cocaína/complicaciones , Trastornos Relacionados con Cocaína/fisiopatología , Epinefrina/metabolismo , Dependencia de Heroína/complicaciones , Dependencia de Heroína/fisiopatología , Serotonina/fisiología , Sistema Nervioso Simpático/fisiopatología , Plaquetas/metabolismo , Trastornos Relacionados con Cocaína/sangre , Dopamina beta-Hidroxilasa/sangre , Epinefrina/sangre , Femenino , Dependencia de Heroína/sangre , Humanos , Masculino , Norepinefrina/sangre , Serotonina/sangreRESUMEN
Cell death and reactive oxygen species production have been suggested to be involved in neurodegeneration induced by the drugs of abuse. In this study we analyze the toxicity of the following drugs of abuse: heroin, morphine, d-amphetamine, and cocaine in undifferentiated PC12 cells, used as dopaminergic neuronal models. Our data show that opioid drugs (heroin and morphine) are more toxic than stimulant drugs (d-amphetamine and cocaine). Toxic effects induced by heroin are associated with a decrease in intracellular dopamine, an increase in DOPAC levels, and the formation of ROS, whereas toxic effects induced by amphetamine are associated with a decrease in intracellular dopamine and in ATP/ADP levels. In contrast with cocaine, both amphetamine and heroin induced features of apoptosis. The data suggest that the death of cultured PC12 cells induced by the drugs of abuse is correlated with a decrease in intracellular dopamine levels, which can be associated with an increased dopamine turnover and oxidative cell injury.
Asunto(s)
Supervivencia Celular/efectos de los fármacos , Cromatina/efectos de los fármacos , Dopamina/metabolismo , Especies Reactivas de Oxígeno/metabolismo , Ácido 3,4-Dihidroxifenilacético/metabolismo , Adenosina Difosfato/metabolismo , Adenosina Trifosfato/metabolismo , Animales , Cocaína/farmacología , Dextroanfetamina/farmacología , Heroína/farmacología , L-Lactato Deshidrogenasa/análisis , Modelos Animales , Morfina/farmacología , Narcóticos/farmacología , Células PC12 , Feocromocitoma , RatasRESUMEN
Drugs of abuse induce the release of dopamine in the central nervous system, particularly in the mesolimbic-mesocortical pathway. As dopamine may act as a neurotoxin, in this study, we analyzed the effects of the drugs of abuse, cocaine, heroin, and amphetamine, on the neurodegeneration of PC12 cells, a dopaminergic cell line, by evaluating the activity of caspase-3 and mitochondrial cytochrome c release. All the drugs were shown to induce caspase-3 activation, similarly to staurosporine, a classical inducer of apoptotic cell death. Furthermore, like staurosporine, the drugs of abuse induced a decrease in mitochondrial cytochrome c content, suggesting the involvement of the mitochondrial apoptotic pathway.
Asunto(s)
Anfetamina/farmacología , Apoptosis/efectos de los fármacos , Cocaína/farmacología , Heroína/farmacología , Animales , Caspasa 3 , Caspasas/metabolismo , Diferenciación Celular/efectos de los fármacos , Citocromos c/metabolismo , Mitocondrias/efectos de los fármacos , Mitocondrias/metabolismo , Células PC12 , Ratas , Trastornos Relacionados con SustanciasRESUMEN
The adrenergic system has long been known to be activated in a situation of stress and thus during opiate withdrawal. A method for detoxification that decreases the stimulation of the sympathetic nervous system will prevent changes of catecholamine levels. Some of such methods have been developed. One of them uses direct transition from heroin to oral naltrexone after deep sedation with midazolam in conjunction with naloxone, droperidol, ondansetron, and clonidine treatment for 24 hours. Can such method prevent adrenergic changes? Moreover, 5-HT has been related to mood disorders. This study aims to determine plasma catecholamines and 5-HT before heroin withdrawal, during the day of the withdrawal, and at the ends of the first day, the first week, and the first 6 months. Forty-three patients with more than 6 years of drug abuse volunteered to seek help to detoxify. After clinical evaluation, blood samples were taken. Plasma catecholamines were isolated by standard alumina procedures and measured by high-performance liquid chromatography with electrochemical detection. Only for NE was there a significant decrease in the day of heroin withdrawal with deep sedation, followed the next day by an increase. During the following days, NE plasma concentrations returned slowly to basal levels. Epinephrine and dopamine plasma levels did not significantly change. Platelet 5-HT levels progressively decreased from the day before detoxification until the last period of observation. We also found that there were no abrupt changes in cardiovascular functions. In conclusion, our results suggest that this type of ultrarapid opiate detoxification prevents the dramatic activation of the autonomic nervous system.
Asunto(s)
Catecolaminas/sangre , Dependencia de Heroína/sangre , Heroína/farmacocinética , Síndrome de Abstinencia a Sustancias/sangre , Adulto , Análisis de Varianza , Vías de Administración de Medicamentos , Quimioterapia Combinada , Femenino , Dependencia de Heroína/metabolismo , Humanos , Inactivación Metabólica , Masculino , Naloxona/administración & dosificación , Naltrexona/administración & dosificación , Antagonistas de Narcóticos/administración & dosificación , Síndrome de Abstinencia a Sustancias/metabolismo , Sístole , Resultado del TratamientoRESUMEN
The surface of an electrochemical glassy carbon electrode was modified with a layer of double-stranded DNA (dsDNA) or with double-stranded DNA conditioned in single-stranded DNA (ssDNA) and was used to investigate mitoxantrone-DNA interactions. Differential pulse and square wave voltammetry were applied to develop an electroanalytical procedure for the determination of mitoxantrone and evaluate its interaction with dsDNA or ssDNA immobilized on the electrode surface. The results demonstrate that MTX interaction with DNA is not specific to either guanine or adenine bases. The kinetics of the mitoxantrone-DNA interaction is slow and damage to DNA was followed with time.
Asunto(s)
Técnicas Biosensibles , ADN/análisis , Mitoxantrona/análisis , Animales , HumanosRESUMEN
Electrical stimulation-induced depolarization releases both dopamine (DA) and noradrenaline (NA) from sympathetic neurones of the human gastric and uterine arteries. The overflow of catecholamines elicited by electrical stimulation was measured by using high performance liquid chromatography with electrochemical detection. The addition of yohimbine (0.01-10 microM), an alpha2-adrenoceptor antagonist, to the perfusion fluid increased, in a concentration-dependent manner, the electrically-evoked DA and NA overflow from gastric and uterine arteries. In the presence of sulpiride (0.01-10 microM), a dopamine D2-type receptor antagonist, the overflow of both amines was found to be increased in the uterine artery, but not in the gastric artery. Apomorphine (0.1-10 microM), a dopamine receptor agonist, produced a dose-dependent inhibition in the amount of DA and NA released from gastric and uterine arteries. SCH 23390 (0.1-10 microM), a dopamine D1 receptor antagonist, had no effect on the release of both amines in both preparations. The inhibitory effect of apomorphine was blocked by sulpiride in the gastric and uterine arteries but not by SCH 23390. The results presented suggest the existence of dopamine D2-type receptors in the human gastric and uterine arteries. They seem to have, in each artery, a different physiological importance.
Asunto(s)
Antagonistas Adrenérgicos alfa/farmacología , Agonistas de Dopamina/farmacología , Antagonistas de Dopamina/farmacología , Dopamina/metabolismo , Músculo Liso Vascular/efectos de los fármacos , Norepinefrina/metabolismo , Receptores de Dopamina D2/efectos de los fármacos , Receptores Presinapticos/efectos de los fármacos , Yohimbina/farmacología , Apomorfina/farmacología , Arterias , Relación Dosis-Respuesta a Droga , Interacciones Farmacológicas , Estimulación Eléctrica , Femenino , Humanos , Músculo Liso Vascular/metabolismo , Estómago , Sulpirida/farmacología , ÚteroRESUMEN
As it has been previously shown that lamotrigine (LTG) accumulates in the kidney of male rats, the purpose of the present investigation was to characterize the kidney profiles of LTG and its kidney distribution pattern in male rats, in order to confirm if a preferential distribution exists and to analyse if it does or does not affect the LTG systemic pharmacokinetics. Adult male Wistar rats were intraperitoneally injected with 5, 10 and 20 mg/kg of LTG. The concentration-time profiles of LTG in plasma and whole kidney were determined over 120 h postdose. The distribution of LTG in the rat kidney was investigated in another group of rats by measuring LTG levels in the renal cortex and medulla. The LTG plasma concentration-time profiles revealed a linear relationship with dose. However, a slight increase in the LTG elimination half-life with dose was observed. In contrast, a nonlinear relationship was established between LTG kidney levels and the dose administered. Consequently, nonparallel patterns were observed between LTG plasma and kidney profiles. The LTG kidney distribution pattern revealed an accumulation of LTG in the renal cortex. The present study demonstrated that LTG distributes preferentially to the kidneys of the male rat in a dose-dependent manner and suggests that such distribution may slightly affect the systemic kinetics of the drug.
Asunto(s)
Anticonvulsivantes/farmacocinética , Riñón/metabolismo , Triazinas/farmacocinética , Animales , Anticonvulsivantes/administración & dosificación , Anticonvulsivantes/sangre , Área Bajo la Curva , Cromatografía Líquida de Alta Presión , Semivida , Inyecciones Intraperitoneales , Corteza Renal/metabolismo , Médula Renal/metabolismo , Lamotrigina , Masculino , Ratas , Ratas Wistar , Triazinas/administración & dosificación , Triazinas/sangreRESUMEN
Given that administration vehicles and drug formulations can affect drug bioavailability, their influence on the pharmacokinetic profile of lamotrigine (LTG), a new-generation anti-epileptic drug, was studied in rats. Three different formulations administered intraperitoneally at a dose of 10 mg/kg were used: (1) LTG suspended in a 0.25% methylcelulose solution, (2) LTG dissolved in a 50% propylene glycol solution, and (3) LTG isethionate dissolved in distilled water. Plasma and brain homogenate levels were determined in order to evaluate vehicle-dependent drug absorption. The results demonstrated rapid absorption of LTG when it was administered as an aqueous solution, in contrast to a slower and more erratic absorption after the injection of either the lipophilic solution or the suspension. A plasma peak was achieved 15 min post-dose with the aqueous solution, with a brain peak being achieved 15 min later, while with the other formulations both plasma and brain homogenate peaks were reached 2 h after LTG administration. This study suggests that LTG isethionate dissolved in distilled water is the most suitable formulation for successful LTG pharmacokinetic studies in rats.
Asunto(s)
Anticonvulsivantes/farmacocinética , Triazinas/farmacocinética , Animales , Anticonvulsivantes/administración & dosificación , Anticonvulsivantes/sangre , Área Bajo la Curva , Disponibilidad Biológica , Encéfalo/metabolismo , Química Farmacéutica , Cromatografía Líquida de Alta Presión , Inyecciones Intraperitoneales , Lamotrigina , Masculino , Vehículos Farmacéuticos , Ratas , Ratas Wistar , Soluciones , Suspensiones , Triazinas/administración & dosificación , Triazinas/sangre , AguaRESUMEN
The metabolism of apomorphine is quite complex due to interactions with proteins and other tissue components that affect its pharmacokinetic profile. The electrochemical oxidation mechanism of apomorphine and of some synthesised apomorphine derivatives was studied. It was found to be related to the reaction of o-diphenol and tertiary amine groups and strongly dependent on pH.
Asunto(s)
Apomorfina/metabolismo , Apomorfina/química , Concentración de Iones de Hidrógeno , Oxidación-ReducciónRESUMEN
The search for drugs with cytostatic activity and with better pharmacokinetic features led to the synthesis of Navelbine (5'-noranhydrovinblastine) which is a structural modification of antitumour Vinca alkaloids. The new drug Navelbine has high liposolubility, a lower toxicity and increased antitumour activity. The electrochemical oxidation of Navelbine was studied over a wide pH range (1.2-12.8) at a glassy carbon disc electrode in buffered aqueous media using differential pulse and cyclic voltammetry. The anodic oxidation mechanism is a very complex, pH dependent, multistep electron transfer process with coupled homogeneous chemical reactions.
Asunto(s)
Antineoplásicos/química , Vinblastina/análogos & derivados , Electrodos , Concentración de Iones de Hidrógeno , Estructura Molecular , Oxidación-Reducción , Vinblastina/química , VinorelbinaRESUMEN
The relaxing effect of dopamine was studied on the dog isolated saphenous vein contracted by prostaglandin F2alpha after alpha-adrenoceptor blockade by phentolamine. This effect is partially inhibited by propranolol and haloperidol suggesting that dopamine has two types of receptors in this vessel: beta- and dopaminergic receptors. However, the results obtained after treatment with drugs that interfere with deamination of catecholamines or after denervating the venous tissue led us to conclude that the agonist substance is not dopamine, but probably one of its deaminated metabolites or a secondary condensation product, namely tetrahydropapaveroline. Adrenaline has also been used to compare the behaviour of the two amines when interference in the deamination process is produced. The dissimilar results obtained with adrenaline are in good agreement with the hypothesis.
Asunto(s)
Dopamina/farmacología , Vasodilatación/efectos de los fármacos , Animales , Desaminación , Perros , Dopamina/metabolismo , Interacciones Farmacológicas , Epinefrina/farmacología , Femenino , Técnicas In Vitro , Masculino , Desnervación Muscular , Fentolamina/farmacología , Prostaglandinas F/farmacología , Vena Safena/efectos de los fármacosRESUMEN
Amphetamines exert their persistent addictive effects by activating brain's reward pathways, perhaps through the release of dopamine in the nucleus accumbens (and/or in other places). On the other hand, there is a relationship between dopamine and all behavioural aspects that involve motor activity and it has been demonstrated that exercise leads to an increase in the synthesis and release of dopamine, stimulates neuroplasticity and promotes feelings of well-being. Moreover, exercise and drugs of abuse activate overlapping neural systems. Thus, our aim was to study the influence of chronic exercise in the mechanism of addiction using an amphetamine-induced conditioned-place-preference in rats.Adult male Sprague-Dawley rats were randomly separated in groups with and without chronic exercise. Chronic exercise consisted in a 8 week treadmill running program, with increasing intensity. The conditioned place preference test was performed in both groups using a procedure and apparatus previously established. A 2 mg.kg(-1) amphetamine or saline solution was administered intraperitonially according to the schedule of the conditioned place preference. Before conditioning none of the animals showed preference for a specific compartment of the apparatus. The used amphetamine dose in the conditioning phase was able to produce a marked preference towards the drug-associated compartment in the group without exercise. In the animals with exercise a significant preference by the compartment associated with saline was observed. These results lead us to conclude that a previous practice of regular physical activity may help preventing amphetamine addiction in the conditions used in this test.
RESUMEN
Serotonergic receptors are involved in many vascular functions, but only a few studies have been made in human vessels. Thus, this study aimed to characterize these receptors in the human uterine artery without endothelium. The pD2 value of serotonin (5-HT) was 5.96, but the intrinsic activity was 59% of that of noradrenaline. Spiperone and ketanserin shifted the concentration-response curves of 5-HT to the right (pA2 = 8.56 and 9.76; slopes = 0.98 and 0.83, respectively). Propranolol, yohimbine, prazosin and atropine did not significantly shift the concentration-response curves to 5-HT. Phentolamine inhibited the 5-HT response (pA2 = 6.69), and previous treatment of the vascular strips with 6-hydroxydopamine only partially reduced such an effect. The results demonstrate the existence, in the human uterine artery, of 5-HT2 receptors which are blocked by high concentrations of phentolamine. In this tissue, 5-HT does not release noradrenaline from perivascular nerves.
Asunto(s)
Receptores de Serotonina/metabolismo , Útero/irrigación sanguínea , Arterias/metabolismo , Endotelio Vascular , Femenino , Humanos , Músculo Liso Vascular/efectos de los fármacos , Serotonina/farmacología , Antagonistas de la Serotonina/farmacología , Simpatectomía Química , Simpaticolíticos/farmacología , Contracción Uterina/efectos de los fármacosRESUMEN
The purpose of this work was to study 'in vivo' the vascular responses of retinal vessels of New Zealand white rabbits to substance P (SP), neurokinin A (NKA), neurokinin B (NKB), senktide, capsaicin (CAPS), and calcitonin gene related peptide (CGRP) before and after selective antagonist administration. We examined the effects of these neuropeptides on the normal circulation in the optic nerve head of the rabbit. Drugs were injected via pars plana through a micropipette system. Ten minutes before perivascular injection of 10 nmol/l sumatriptan (to contract the vessel), a selective antagonist or its solvent was administered. Then, cumulative injection of the agonist was performed. The other eye was used as control. Direct measurement of retinal arteriole diameters was performed using digital angiography. The quantification of the relaxing effect is expressed as percentage related to the precontracted vascular diameter. Microinjection of SP (NK1 receptor agonist) up to 10 nmol/l induced a dose-dependent arteriolar dilating effect [E(max) (mean +/- SEM) 21.3 +/- 2.3%]. After the perivascular preinjection of 1 nmol/l L-668,169 or 1 nmol/l L-733,060 (NK1 receptor antagonists), the SP dose-response curve was shifted to the right. The same results were obtained with NKA (NK2 receptor agonist) which induced the most potent effect of all neuropeptides (E(max) 53.3+/-2.5%). The NK2 receptor antagonists L-659,877 and GR 159897 (1 nmol/l) strongly inhibited this arteriolar vasodilation. As for CGRP, doses up to 10 nmol/l induced a marked vasodilation (E(max) 41.1+/-0.4%) which decreased after microinjection of the selective antagonist CGRP8-37. The NK3 receptor agonists (senktide and NKB) showed a minor vasodilating effect (E(max) 5.1+/-1.2 and 8.0+/-0.9%, respectively). On the contrary, CAPS showed a marked dose-dependent vasodilating effect (E(max) 43.2+/-2.9%), antagonized by the tachykinin receptor antagonists and CGRP8-37. These results suggest, for the first time, the presence of NK1, NK2, and CGRP receptors on the retinal arteriolar wall of the rabbit.
Asunto(s)
Péptido Relacionado con Gen de Calcitonina/farmacología , Neuropéptidos/farmacología , Nervio Óptico/irrigación sanguínea , Sustancia P/análogos & derivados , Sumatriptán/efectos adversos , Animales , Arteriolas/efectos de los fármacos , Barrera Hematorretinal/efectos de los fármacos , Péptido Relacionado con Gen de Calcitonina/antagonistas & inhibidores , Capsaicina/antagonistas & inhibidores , Capsaicina/farmacología , Relación Dosis-Respuesta a Droga , Femenino , Masculino , Microinyecciones , Neuroquinina A/antagonistas & inhibidores , Neuroquinina A/farmacología , Neuroquinina B/farmacología , Antagonistas del Receptor de Neuroquinina-1 , Nervio Óptico/efectos de los fármacos , Nervio Óptico/fisiopatología , Fragmentos de Péptidos/antagonistas & inhibidores , Fragmentos de Péptidos/farmacología , Conejos , Receptores de Péptido Relacionado con el Gen de Calcitonina , Receptores de Neuroquinina-1/fisiología , Receptores de Neuroquinina-2/antagonistas & inhibidores , Receptores de Neuroquinina-2/fisiología , Vasos Retinianos/efectos de los fármacos , Vasos Retinianos/fisiología , Sustancia P/farmacología , Sumatriptán/administración & dosificación , Sumatriptán/farmacocinética , Vasodilatación/efectos de los fármacos , Vasodilatación/fisiologíaRESUMEN
The role of the serotonin system in the etiology and pathogenesis of autism spectrum disorders (ASD) is not clearly defined. High levels of platelet serotonin (5-HT) have been consistently found in a proportion of patients, and it is known that specific 5-HT transporter gene (SLC6A4) variants modulate transporter reuptake function, therefore possibly influencing the occurrence of hyperserotonemia in a subset of autistic patients. We have examined the association of platelet serotonin levels with two SLC6A4 polymorphisms, 5-HTT gene-linked polymorphic region (HTTLPR) in the promoter and intron 2 variable number of tandem repeats (VNTR), in a sample of 105 ASD patients, their parents, and 52 control children. Quantitative transmission disequilibrium test (QTDT) results showed a significant effect on 5-HT levels of each SLC6A4 marker (P=0.017 for HTTLPR; P=0.047 for intron 2 VNTR) and of haplotypes of the two markers (P=0.017), with a major contribution of the L.Stin2.10 haplotype (P=0.0013). A 5-HT mean value in the range of hyperserotonemia was associated with the homozygous L.Stin2.10 haplotype (H (1,N=97)=7.76, P=0.0054), which occurred in 33% of hyperserotonemic patients against 6% of patients with normal 5-HT levels (Fisher's exact test: P=0.013, OR=8). Allele interaction at the HTTLPR locus was found, with a significant dominance variance effect on 5-HT levels. We found no transmission disequilibrium of any of the SLC6A4 variants in ASD. Our results show that the SLC6A4 gene is a significant factor in the determination of 5-HT levels, and that specific SLC6A4 variants are associated with an increased risk for hyperserotonemia in our sample of autistic patients. The biological mechanism, however, is unlikely to involve the SLC6A4 gene solely. The associated SLC6A4 alleles likely interact with other genes or environmental factors to produce the abnormally high 5-HT levels observed in this subset of autistic patients, who possibly represent a separate etiological group.
Asunto(s)
Trastorno Autístico/genética , Variación Genética , Enfermedades Metabólicas/sangre , Enfermedades Metabólicas/genética , Serotonina/sangre , Adolescente , Trastorno Autístico/sangre , Azores , Niño , Preescolar , Marcadores Genéticos , Humanos , Intrones/genética , Portugal , Valores de Referencia , Factores de RiesgoRESUMEN
Acute changes in dopamine (DA) turnover were studied in the caudate nucleus (CN) of adult male rats between 0-24 h after a single injection of Methamphetamine (20 mg/kg, ip). A single dose of METH-induced an increase in DA turnover [(DOPAC + HVA)/DA] concomitant with an acute DA release followed by transient DA and DOPAC depletion in the rat CN.
Asunto(s)
Trastornos Relacionados con Anfetaminas/metabolismo , Núcleo Caudado/efectos de los fármacos , Inhibidores de Captación de Dopamina/farmacología , Dopamina/metabolismo , Metanfetamina/farmacología , Terminales Presinápticos/efectos de los fármacos , Ácido 3,4-Dihidroxifenilacético/metabolismo , Enfermedad Aguda , Trastornos Relacionados con Anfetaminas/fisiopatología , Animales , Núcleo Caudado/metabolismo , Relación Dosis-Respuesta a Droga , Regulación hacia Abajo/efectos de los fármacos , Regulación hacia Abajo/fisiología , Esquema de Medicación , Ácido Homovanílico/metabolismo , Masculino , Terminales Presinápticos/metabolismo , Ratas , Ratas Sprague-DawleyRESUMEN
The present report describes a case of Sezary syndrome in a canine with lymphadenomegaly, generalized erithroderma, intense pruritus and disseminated cutaneous nodules and plaques. Biopsy samples were taken from cutaneous nodules and plaques and were diagnosed epitheliotropic T cell cutaneous lymphoma by histology and immunohistochemical stain. Bone marrow cytology confirms leukemia. Diagnosis of Sezary syndrome was achieved through clinical, hematological, citopathological, histopathological and immunohistochemical findings. The patient was treated with Madison-Wisconsin chemotherapy protocol, but died after two mouths of treatment